Edward V Loftus

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Venues

Alimentary pharmacology & therapeutics

Crohn's & colitis 360

Inflammatory bowel diseases

Journal of Crohn's & colitis

Mayo Clinic Rochester

Villanova University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Rochester

United States

Professor of Medicine :: Division of Gastroenterology and Hepatology

Education History

Villanova University

United States

BSC

Publications

Subrata Ghosh, Brian G Feagan, Elyssa Ott, Christopher Gasink, Bridget Godwin, Colleen Marano, Ye Miao, Tony Ma, Edward V Loftus, William J Sandborn, Silvio Danese, Maria T Abreu, Bruce E Sands
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis. Journal of Crohn's & colitis 18 (7) (2024)
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese, Edward V Loftus, Ian L P Beales, Stefan Schreiber, Hyo Jong Kim, Margaux Faes, Angela de Haas, Tomasz Masior, Christine Rudolph, Laurent Peyrin Biroulet
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics (2024)
Mika Yamanaka-Takaichi, Soheila Nadalian, Edward V Loftus, Eric C Ehman, Austin Todd, Anna B Grimaldo, Mariana Yalon, Caroline L Matchett, Nisha B Patel, Nasro A Isaq, Laura E Raffals, David A Wetter, Dennis H Murphree, Robert R Cima, Eric J Dozois, Noah Goldfarb, Hamid R Tizhoosh, Afsaneh Alavi
Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa. International journal of dermatology (2024)
Subrata Ghosh, Brian G Feagan, Elyssa Ott, Christopher Gasink, Bridget Godwin, Colleen Marano, Ye Miao, Tony Ma, Edward V Loftus, William J Sandborn, Silvio Danese, Maria T Abreu, Bruce E Sands
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis. Journal of Crohn's & colitis 18 (7) (2024)
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese, Edward V Loftus, Ian L P Beales, Stefan Schreiber, Hyo Jong Kim, Margaux Faes, Angela de Haas, Tomasz Masior, Christine Rudolph, Laurent Peyrin Biroulet
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics 60 (5) (2024)
Jonathan T Pham, Wissam Ghusn, Andres Acosta, Edward V Loftus, Amanda M Johnson
Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease. The American journal of gastroenterology (2023)
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Severine Vermeire, Christian Maaser, Silvio Danese, Margaux Faes, Paul Van Hoek, Jeremy Hsieh, Ulrik Moerch, Yan Zhou, Angela de Haas, Christine Rudolph, Alessandra Oortwijn, Edward V Loftus
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Alimentary pharmacology & therapeutics (2023)
Edward V Loftus, Ashwin N Ananthakrishnan, Wan-Ju Lee, Yuri Sanchez Gonzalez, Kristina A Fitzgerald, Kori Wallace, Wen Zhou, Leighann Litcher-Kelly, Sarah B Ollis, Sylvia Su, Silvio Danese
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative Colitis. PharmacoEconomics - open (2023)
Remo Panaccione, Silvio Danese, Wen Zhou, Justin Klaff, Dapo Ilo, Xuan Yao, Gweneth Levy, Peter D R Higgins, Edward V Loftus, Su Chen, Yuri Sanchez Gonzalez, Carolyn Leonard, Xavier Hébuterne, James O Lindsay, Qian Cao, Hiroshi Nakase, Jean Frederic Colombel, Séverine Vermeire
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis. Alimentary pharmacology & therapeutics (2023)
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott David Lee, Wan-Ju Lee, Jenny Griffith, Kori Wallace, Sofie Berg, Xiaomei Liao, Julian Panes, Edward V Loftus, Edouard Louis
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Alimentary pharmacology & therapeutics (2022)
Thomas W Fredrick, Guilherme Piovezani Ramos, Manuel B Braga Neto, Sunanda V Kane, William A Faubion, Edward V Loftus, Darrell S Pardi, Shabana F Pasha, Francis A Farraye, Lizhi Zhang, Laura E Raffals
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohn's & colitis 360 4 (2) (2022)
Thomas W Fredrick, Guilherme Piovezani Ramos, Manuel B Braga Neto, Sunanda V Kane, William A Faubion, Edward V Loftus, Darrell S Pardi, Shabana F Pasha, Francis A Farraye, Lizhi Zhang, Laura E Raffals
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohn's & colitis 360 4 (2) (2022)
Guilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, Laurens P Janssens, Kenneth W Hung, Deborah Proctor, Elizabeth Ruggiero, Sunanda Kane, David H Bruining, William A Faubion, Laura E Raffals, Edward V Loftus, Badr Al-Bawardy
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflammatory bowel diseases 27 (8) (2022)
Satimai Aniwan, Priscila Santiago, Edward V Loftus, Sang Hyoung Park
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European gastroenterology journal (2022)
Ailsa Hart, Geert D'Haens, Mareike Bereswill, Tricia Finney-Hayward, Jasmina Kalabic, Gweneth Levy, Huifang Liang, Cynthia H-T Seow, Edward V Loftus, Remo Panaccione, Walter Reinisch, Jack Satsangi
Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis. United European gastroenterology journal 10 (5) (2022)
Zeinab Bakhshi, Siddhant Yadav, W Scott Harmsen, Jithinraj Edakkanambeth Varayil, Kevin A Karls, William J Tremaine, Edward V Loftus
Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes. Inflammatory bowel diseases (2022)
Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly, Leonardo Salese, Chinyu Su, Kenneth K Kwok, John C Woolcott, Alessandro Armuzzi
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program. Inflammatory bowel diseases (2022)
Guilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, Adam C Bledsoe, Kevin P Quinn, Valérie Heron, Maria Alice V Willrich, Amanda Johnson, Victor G Chedid, Nayantara Coelho-Prabhu, John B Kisiel, Konstantinos A Papadakis, Darrell Pardi, Sunanda V Kane, William J Tremaine, Laura E Raffals, David H Bruining, William A Faubion, William S Harmsen, Edward V Loftus
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohn's & colitis 360 3 (3) (2021)
Guilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, Adam C Bledsoe, Kevin P Quinn, Valérie Heron, Maria Alice V Willrich, Amanda Johnson, Victor G Chedid, Nayantara Coelho-Prabhu, John B Kisiel, Konstantinos A Papadakis, Darrell Pardi, Sunanda V Kane, William J Tremaine, Laura E Raffals, David H Bruining, William A Faubion, William S Harmsen, Edward V Loftus
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohn's & colitis 360 3 (3) (2021)
William J Sandborn, Nervin Lawendy, Silvio Danese, Chinyu Su, Edward V Loftus, Ailsa Hart, Iris Dotan, Adérson O M C Damião, Donna T Judd, Xiang Guo, Irene Modesto, Wenjin Wang, Julian Panés
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment. Alimentary pharmacology & therapeutics (2021)
Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer, Gursimran Kochhar, Brigid Boland, Siddharth Singh, Robert P Hirten, Ryan C Ungaro, Eugenia Shmidt, Karen Lasch, Vipul Jairaith, David Hudesman, Shannon Chang, Dana Lukin, Arun Swaminath, Bruce E Sands, Jean Frederic Colombel, Sunanda Kane, Edward V Loftus, Bo Shen, Corey A Siegel, William J Sandborn, Parambir S Dulai, null null
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Alimentary pharmacology & therapeutics 52 (4) (2020)
Edward V Loftus, Brian G Feagan, Remo Panaccione, Jean Frederic Colombel, William J Sandborn, Bruce E Sands, Silvio Danese, Geert R A M D'Haens, David T Rubin, Ira Shafran, Andrejus Parfionovas, Raquel Rogers, Richard A Lirio, Severine Vermeire
Long-term safety of vedolizumab for inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (8) (2020)
Edward V Loftus, Bruce E Sands, Jean-Frédéric Colombel, Iris Dotan, Javaria Mona Khalid, David Tudor, Parnia Geransar
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1. Clinical and experimental gastroenterology 13 (2020)
Zeinab Bakhshi, Siddhant Yadav, Bradley R Salonen, Sara L Bonnes, Jithinraj Edakkanambeth Varayil, William Scott Harmsen, Ryan T Hurt, William J Tremaine, Edward V Loftus
Incidence and Outcomes of Home Parenteral Nutrition in Patients With Crohn Disease in Olmsted County, Minnesota. Crohn's & colitis 360 2 (4) (2020)
Gursimran S Kochhar, Aakash Desai, Aslam Syed, Abhinav Grover, Sandra El Hachem, Heitham Abdul-Baki, Preethi Chintamaneni, Elie Aoun, Sowjanya Kanna, Dalbir S Sandhu, Siddharth Singh, Bo Shen, Edward V Loftus, Parambir S Dulai
Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications. Alimentary pharmacology & therapeutics 51 (11) (2020)
Parambir S Dulai, Aurelien Amiot, Laurent Peyrin Biroulet, Vipul Jairath, Melanie Serrero, Jerome Filippi, Siddharth Singh, Benjamin Pariente, Edward V Loftus, Xavier Roblin, Sunanda Kane, Anthony Buisson, Corey A Siegel, Yoram Bouhnik, William J Sandborn, Karen Lasch, Maria Rosario, Brian G Feagan, Daniela Bojic, Caroline Trang-Poisson, Bo Shen, Romain Altwegg, Bruce E Sands, Jean Frederic Colombel, Franck Carbonnel, null null
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Alimentary pharmacology & therapeutics 51 (5) (2019)

Edward V Loftus.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Edward V Loftus